➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Mallinckrodt
Express Scripts
Medtronic
Merck

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Litigation Details for Reckitt Benckiser Pharmaceuticals, Inc. v. Biodelivery Sciences International, Inc. (E.D.N.C. 2015)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Reckitt Benckiser Pharmaceuticals, Inc. v. Biodelivery Sciences International, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Reckitt Benckiser Pharmaceuticals, Inc. v. Biodelivery Sciences International, Inc. (E.D.N.C. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 27 infringement of a patent related to Suboxone, U.S. Patent No. 8,765,167 (the “’167 patent”). (Pls.’ Opp’n…making it. (Ia'. il 15; Ex. A-l, U.S. Patent No. 8,765,167, Abstract (filed Sep. 8, 2006), ECF No. …’832 Patent or U.S. Patent No. 7,897,080 (the “’08() Patent”).4 (Ia'. il 7.) The ’080 Patent is owned…alleged that Bunavail infringed U.S. Patent No. 8,4752832 (the “’832 Patent”). (Ic!. iiil 42-5 l .) RBP and…exclusive licensees of the Patent. (Chiistie Decl., Ex. 5 il 9.) The ’832 Patent is entitled “Sublingual External link to document
0000-00-00 42 proceedings concerning U.S. Patent No. 8,765,167 at the United States Patent and Trademark Office, including… non-appealable decision concerning U.S. Patent No. 8,765,167. Signed by Chief Judge James C. Dever III…non- appealable decision concerning U.S. Patent No. 8,765,167. 3. The motion to dismiss [D.E. … 21 July 2015 5:15-cv-00350 830 Patent Plaintiff District Court, E.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
AstraZeneca
McKinsey
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.